This site is intended for Payer Professionals only
Important Safety Information
Billing Codes
BILLING CODES

Help improve the lives of your employees living with diabetes

As an employer, you have the power to make a difference by being a reliable source of health information1 and providing
the right resources.

The impact of diabetes on your employees and your business

 

A total of 1 in 3 Americans will develop diabetes at some point in their lifetime2

 

 

 

 

14 million lost days due to workplace diabetes-related absenteeism3

The cost of missed workdays (ranging from 1.0 to 4.2 days per employee) due to diabetes-related absenteeism is estimated at $3.3 billion3.

A total of 1 in 3 Americans will develop diabetes at some point in their lifetime A total of 1 in 3 Americans will develop diabetes at some point in their lifetime A total of 1 in 3 Americans will develop diabetes at some point in their lifetime

Get resources to support your employees

Employer Tool Kit

A guide designed to empower employers to provide diabetes support in the workplace.


How FreeStyle Libre systems can help

Continuous glucose monitors (CGMs) have been shown to be effective tools for managing diabetes*4-6

Attaining target glucose levels and maintaining glucose control are important for short-term and long-term outcomes in people with diabetes6,7. The FreeStyle Libre portfolio of CGM systems can give people with diabetes a better understanding of glucose fluctuations, and work alongside changes in diet, exercise, and medication to help them improve their own outcomes.

 

Abbott has also partnered with top companies that develop automated insulin delivery (AID) systems to integrate FreeStyle Libre 2 plus and FreeStyle Libre 3 plus sensors for more streamlined insulin delivery8.

LEARN MORE ABOUT FREESTYLE LIBRE SYSTEMS
Man wearing FreeStyle Libre 3 plus sensor Man wearing FreeStyle Libre 3 plus sensor

Let's talk

Learn more about how Abbott and the FreeStyle Libre portfolio can help you make a difference in the lives of your employees with CGM systems.

Connect Now

The FreeStyle Libre 3 system includes FreeStyle Libre 3 Plus and FreeStyle Libre 3 sensors, the Libre app, and the FreeStyle Libre 3 reader.

 

Medicare and other payor criteria may apply.

 

The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.


 

The FreeStyle Libre systems apps and the FreeStyle Libre systems readers have similar but not identical features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.

*   Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 system, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.

REFERENCES: 1. 2024 Edelman Trust Barometer Special Report. https://www.edelman.com/sites/g/files/aatuss191/files/2024-04/2024%20Edelman%20Trust%20Barometer%20Trust%20and%20Health_1.pdf Accessed January 24, 2025. 2. Centers for Disease Control and Prevention. “Health and Economic Benefits of Diabetes Interventions.” https://www.cdc.gov/nccdphp/priorities/diabetes-interventions.html Accessed January 24, 2025. 3. American Diabetes Association. Diabetes Care (2018): https://doi.org/10.2337/dci18-0007 Accessed January 24, 2025. 4. Bergenstal, R. J Endocr Soc (2021): https://doi.org/10.1210/jendso/bvab013 5. Charleer S, et al. Diabetes Care (2020): https://doi.org/10.2337/dc19-1610 6. Fokkert, M. BMJ Open Diabetes Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809 7. "Health Disparities in Employer-Sponsored Insurance-Morgan Health-NORG" (2022). https://www.jpmorganchase.com/content/dam/jpmc/jpmorgan-chase-and-co/who-we-are/our-business/documents/jpmc-morgan-health-norc-report-ada.pdf Accessed January 24, 2025. 8. Abbott MediaRoom. https://abbott.mediaroom.com/2024-08-07-Abbott-Enters-Global-Partnership-to-Connect-Its-World-Leading-Continuous-Glucose-Monitoring-System-with-Medtronics-Insulin-Delivery-Devices Accessed January 24, 2025. 

ADC-70161 v3.0

Important Safety Information

FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.


No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

ADC-85718 v5.0

Disclaimer

Payer.freestylelibre.us/en is a product-specific website intended only for residents of the United States.

If you are a resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

ADC-21099 v3.0 07/21